When it comes to the real impact of the U.S. Supreme Court’s decision in KSR v. Teleflex, the jury is still out. Some say it will lead to a fundamental change in how patents are obtained and litigated, while others say not much will really change. This disagreement requires a thoughtful discussion of how companies will need to adapt to protect their current intellectual property portfolios and to adjust their strategies moving forward.
In the second installment of Foley’s Patent Nation Web Conference Series, we considered:
- What impact will the Court’s decision have on inventors, businesses, and innovators in the United States?
- Will it now be harder for start-up companies and inventors to obtain venture capital funding?
- What are the financial implications?
- Will the decision help established companies avoid competition?
- Will KSR affect the rate of innovation? If so, will it increase or decrease?
- How are the courts reacting to the new standard established by KSR?
- What will be the effect of KSR on the United States Patent and Trademark Office’s workload and turnaround time?
Speakers:
- Thomas Elkind, Partner, Intellectual Property Litigation Practice, Foley
- Robert Glance, Associate General Counsel, Fannie Mae
- Roger Kitterman, Associate Director, Center for Innovative Ventures, Partners HealthCare
- Curtis Rose, Assistant General Counsel, Hewlett-Packard Company
Additional Program in this Web Conference Series include:
- Tuesday, May 15, 2007
Patent Nation: Real or Hype? Business and Litigation Impact of Patent Reform - Wednesday, September 12, 2007
Patent Nation: Jon W. Dudas on the New USPTO Claims & Continuations Rules
People
Related Insights
December 5, 2025
Labor & Employment Law Perspectives
Ninth Circuit Ruling Upholds Employee Speech Amid Stalled NLRB
Like it or not, social media has become the backdrop of almost everything we do. It's how many people read the news, interact with…
December 5, 2025
Legal News: International Trade Enforcement & Compliance
What Every Multinational Should Know About … Preserving the Right to IEEPA Tariff Refunds
Any company that has imported goods subject to the Trump administration’s fentanyl-based tariffs or reciprocal tariffs — i.e., the tariffs levied pursuant to the International Emergency Economic Powers Act (the IEEPA tariffs) — needs to consider filing an action in the U.S. Court of International Trade (CIT) to preserve the possibility of recovering refunds of these tariffs.
December 4, 2025
Manufacturing Industry Advisor
Foley Automotive Update
Analysis by Julie Dautermann, Competitive Intelligence Analyst Foley is here to help you through all aspects of rethinking your long-term…